Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17652651 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: rofecoxib;   Procedure: adjuvant therapy

Indicates status has not been verified in more than two years